However, short time treatment with DAVANAT® of tumor infiltrating lymphocytes (TIL) isolated from human tumor ascites boosts cytotoxicity of CD8+ TILs and their IFN-γ secretion in a dose dependent manner (16). Here, CD8A is linked to neoplasm.